ADITI ADHIKARI: Open Payments
NPI 1346956422 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 42 payments from 12 companies in 2025. Trend: 2023 $672 · 2024 $1,012 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $375 |
| PFIZER INC. | 8 | $137 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Collegium Pharmaceutical, Inc. | 5 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $79 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $50 |
| Orexo US, Inc. | 3 | $49 |
| Braeburn Inc. | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $19 |
Products named: QULIPTA, NURTEC ODT, LINZESS, Symbravo, RELISTOR, XTAMPZA, JOURNAVX, Zubsolv.
Industry payments across WI — which companies pay providers there.
